In a new systematic review, Chr. Hansen scientists have compiled data from 26 clinical studies on HMOs, concluding there is a wealth of evidence that these are well-tolerated modulators of the gut microbiome providing health benefits.
The US FDA has issued ‘Good Day Letters’ to dsm-firmenich for three Generally Recognized as Safe (GRAS) notices submitted for the human milk oligosaccharides (HMOs) LNFP-l/2’-FL and hypoallergenic grade LNnT and 2’-FL.
A new study analysing the HMO contents of breastmilk during the infant’s first 12-weeks of life, observes that greater intakes of fucosylated types correlated with higher scores for executive function at age three.
Adam Baker, director of science at Chr. Hansen, discussed recent in-house clinical trials observing an amplified response following administration of probiotics with HMOs, compared with pre- or probiotics given alone, at Probiota last week.
Breastfeeding mothers with a higher intake of vegetables, vitamins and metal elements produced more human milk oligosaccharides (HMOs) in their breast milk, according to an observational study funded by Abbott Nutrition R&D Center in Shanghai.
Plant-derived macronutrients are positively associated with higher pregnancy and postpartum human milk oligosaccharides (HMO) in breastmilk and could help mitigate the risk of allergies among infants, according to a study funded by Abbott Nutrition.
Individual human milk oligosaccharides (HMOs) may play critical roles in the maturation of gray matter in an infant brain, showing that inclusion of specific HMOs in infant formula could be beneficial, says a new study.
Chr. Hansen has received regulatory approval to supply a range of Human Milk Oligosaccharides (HMO) to new and existing global markets, following recent endorsements from Australia and New Zealand last year.
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
A novel probiotics encapsulation technology, H&H Group’s pioneering research on HMObiotics, curcumin’s benefits on cognitive health are some of the stories covered in this round-up of new scientific findings.
Major nutrition company Health and Happiness (H&H Group) is pioneering research on how the right pairings of human milk oligosaccharides (HMOs) and probiotics – a novel category known as ‘HMObiotics’ – could bring about health benefits for consumers...
Research into the postpartum variations in human milk oligosaccharides (HMOs) adds weight to the argument that extended breastfeeding is beneficial to infant development and may facilitate the development of new infant formula fortified with HMOs.
Over the last 20 years, the increase in exclusive breastfeeding and formula milk consumption, particularly in upper-middle-income countries, has led to product makers and ingredient suppliers revising plans in order to meet demand.
Biomilq is a women-owned infant nutrition company that is producing cultured breastmilk in a lab. The company’s co-founder and CSO, Leila Strickland, PhD, sat down to discuss the inspiration behind this new kind of infant formula.
Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.
Supplementation with the human milk oligosaccharides (HMOs) HMOs 2'-fucosyllactose (2'FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.
Existing research on human milk oligosaccharides (HMOs) is only at the tip of the iceberg and there are vast opportunities for developing new pre/probiotics/synbiotics with HMOs, says an expert specialising in this field.